A detailed history of Morgan Stanley transactions in Cardlytics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 356,123 shares of CDLX stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
356,123
Previous 2,165,932 83.56%
Holding current value
$1.2 Million
Previous $17.8 Million 93.59%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.96 - $9.15 $5.36 Million - $16.6 Million
-1,809,809 Reduced 83.56%
356,123 $1.14 Million
Q2 2024

Oct 17, 2024

SELL
$8.03 - $15.41 $994,178 - $1.91 Million
-123,808 Reduced 5.41%
2,165,932 $17.8 Million
Q2 2024

Aug 14, 2024

SELL
$8.03 - $15.41 $994,178 - $1.91 Million
-123,808 Reduced 5.41%
2,165,932 $17.8 Million
Q1 2024

Oct 17, 2024

BUY
$5.77 - $20.25 $714,372 - $2.51 Million
123,808 Added 5.72%
2,289,740 $33.2 Million
Q1 2024

Aug 16, 2024

BUY
$5.77 - $20.25 $6.79 Million - $23.8 Million
1,176,720 Added 105.72%
2,289,740 $33.2 Million
Q1 2024

May 15, 2024

BUY
$5.77 - $20.25 $6.79 Million - $23.8 Million
1,176,720 Added 105.72%
2,289,740 $33.2 Million
Q4 2023

Aug 16, 2024

SELL
$6.11 - $14.1 $6.43 Million - $14.8 Million
-1,052,912 Reduced 48.61%
1,113,020 $10.3 Million
Q4 2023

Feb 13, 2024

BUY
$6.11 - $14.1 $2.39 Million - $5.52 Million
391,479 Added 54.26%
1,113,020 $10.3 Million
Q3 2023

Nov 15, 2023

BUY
$5.78 - $19.17 $2.09 Million - $6.93 Million
361,283 Added 100.28%
721,541 $11.9 Million
Q2 2023

Aug 14, 2023

SELL
$3.45 - $8.29 $157,906 - $379,433
-45,770 Reduced 11.27%
360,258 $2.28 Million
Q1 2023

May 15, 2023

SELL
$2.6 - $8.98 $166,678 - $575,680
-64,107 Reduced 13.64%
406,028 $1.38 Million
Q4 2022

Feb 14, 2023

BUY
$3.67 - $10.06 $926,109 - $2.54 Million
252,346 Added 115.87%
470,135 $2.72 Million
Q3 2022

Nov 14, 2022

SELL
$9.32 - $23.54 $4.24 Million - $10.7 Million
-455,181 Reduced 67.64%
217,789 $2.05 Million
Q2 2022

Oct 27, 2022

SELL
$21.88 - $57.86 $2.13 Million - $5.64 Million
-97,483 Reduced 12.65%
672,970 $15 Million
Q2 2022

Aug 15, 2022

SELL
$21.88 - $57.86 $2.13 Million - $5.64 Million
-97,483 Reduced 12.65%
672,970 $15 Million
Q1 2022

Oct 27, 2022

BUY
$42.67 - $72.15 $4.16 Million - $7.03 Million
97,483 Added 14.49%
770,453 $42.4 Million
Q1 2022

May 13, 2022

SELL
$42.67 - $72.15 $7.42 Million - $12.5 Million
-173,874 Reduced 18.41%
770,453 $42.4 Million
Q4 2021

Feb 14, 2022

BUY
$62.36 - $92.74 $609,132 - $905,884
9,768 Added 1.05%
944,327 $62.4 Million
Q3 2021

Nov 15, 2021

BUY
$77.81 - $132.88 $72.7 Million - $124 Million
934,559 New
934,559 $78.4 Million

Others Institutions Holding CDLX

About Cardlytics, Inc.


  • Ticker CDLX
  • Exchange NASDAQ
  • Sector Communication Services
  • Industry Advertising Agencies
  • Shares Outstandng 32,893,800
  • Market Cap $111M
  • Description
  • Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...
More about CDLX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.